Sanara MedTech Q2 EPS $(0.22) Misses $(0.13) Estimate, Sales $15.75M Miss $16.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
Sanara MedTech reported Q2 losses of $0.22 per share, missing the analyst consensus estimate of $0.13 by 69.23%. The company also reported quarterly sales of $15.75 million, missing the estimate of $16.90 million by 6.79%. However, both figures represent an increase from the same period last year.
August 14, 2023 | 8:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sanara MedTech's Q2 earnings and sales missed estimates, which could negatively impact the stock in the short term. However, the year-over-year improvement might mitigate some of the negative impact.
Sanara MedTech's Q2 earnings and sales fell short of analyst estimates, which could lead to a negative sentiment among investors and a potential drop in the stock price. However, the fact that both earnings and sales have improved compared to the same period last year might provide some positive sentiment, potentially mitigating some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100